alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 14,576–14,600 of 27,380 studies, newest first · page 584 of 1096.

November 2017 25

  1. 2017-11-24

    Centiloid method evaluation for amyloid PET of subcortical vascular dementia

    ✓ Peer-reviewed Brain scans and imaging Scientific reports

    Key finding: In 57 [C-11] Pittsburgh compound B (PiB) positive (+) AD and 23 PiB (+) SVaD patients, we assessed standardized PiB uptake and Centiloid scores in disease-specific cortical regions, with several reference regions: cerebellar gray (CG), whole cerebellum (WC), WC with brainstem (WC + B), pons, and white matter (WM). +4 more findings

    Full summary, score breakdown and related studies → Original source

  2. 2017-11-24

    Forging a Frailty-Ready Healthcare System to Meet Population Ageing

    ✓ Peer-reviewed End-of-life care International journal of environmental research and public health

    Key finding: This paper will describe initiatives within the RHS frameworks of the National Health Group (NHG) and the Alexandra Health System (AHS) to forge a frailty-ready healthcare system across the spectrum, which includes the well healthy ("living well"), the well unhealthy ("living with illness"), the unwell unhealthy ("living with frailty"), and the end-of-life (EoL) ("dying well"). +4 more findings

    Full summary, score breakdown and related studies → Original source

  3. 2017-11-24

    Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease

    ✓ Peer-reviewed Inflammation and the immune system Pharmacological research

    Key finding: The exact pathophysiology of this disease remains incompletely understood and safe and effective therapies are required. +3 more findings

    Full summary, score breakdown and related studies → Original source

  4. 2017-11-24

    Idiopathic REM sleep behaviour disorder and neurodegeneration - an update

    ✓ Peer-reviewed Risk factors Nature reviews. Neurology

    Key finding: Given the very high risk that patients with idiopathic RBD have of developing α-synucleinopathies, such as Parkinson disease (PD), PD dementia, dementia with Lewy bodies or multiple system atrophy, and the outstandingly high specificity and very long interval between the onset of idiopathic RBD and the clinical manifestations of α-synucleinopathies, the prodromal phase of this disorder represents a unique opportunity for potentially disease-modifying intervention. +4 more findings

    Full summary, score breakdown and related studies → Original source

  5. 2017-11-24

    Validation of Noninvasive Tracer Kinetic Analysis of 18F-Florbetaben PET Using a Dual-Time-Window Acquisition Protocol

    ✓ Peer-reviewed Biomarkers Journal of nuclear medicine : official publication, Society of Nuclear Medicine

    Key finding: An acquisition protocol using time windows of 0-30 and 120-140 min with appropriate interpolation of the missing time points provided the best compromise between patient comfort and quantification accuracy. +4 more findings

    Full summary, score breakdown and related studies → Original source

  6. 2017-11-23

    Racial Differences in Caregiving: Variation by Relationship Type and Dementia Care Status

    ✓ Peer-reviewed Disparities Journal of aging and health

    Key finding: After covariate adjustment, there were few significant racial differences in caregiving strain, health, and service use. +4 more findings

    Full summary, score breakdown and related studies → Original source

  7. 2017-11-23

    Determinants of late-life depression in residents of long-term care facility

    ✓ Peer-reviewed Risk factors Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego

    Key finding: Depression symptoms were observed in 33.8% of LTCF residents. +4 more findings

    Full summary, score breakdown and related studies → Original source

  8. 2017-11-23

    Type 2 diabetes mellitus and cerebrospinal fluid Alzheimer's disease biomarker amyloid β1-42 in Alzheimer's Disease Neuroimaging Initiative participants

    ✓ Peer-reviewed Tau biomarkers Alzheimer's & dementia (Amsterdam, Netherlands)

    Key finding: CSF Aβ1-42 was higher in the T2DM group than the nondiabetic group. +4 more findings

    Full summary, score breakdown and related studies → Original source

  9. 2017-11-22

    Burden among Family Caregivers of Dementia in the Oldest-Old: An Exploratory Study

    ✓ Peer-reviewed Caregiving Frontiers in medicine

    Key finding: Oldest-old care recipients were more impaired in cognitive function and instrumental ADL; there was no difference in behavior and basic ADL. +4 more findings

    Full summary, score breakdown and related studies → Original source

  10. 2017-11-22

    The Role of Glucagon-Like Peptide 1 (GLP1) in Type 3 Diabetes: GLP-1 Controls Insulin Resistance, Neuroinflammation and Neurogenesis in the Brain

    ✓ Peer-reviewed Drug development International journal of molecular sciences

    Key finding: Several studies have demonstrated that GLP-1 alleviates learning and memory dysfunction by enhancing the regulation of glucose in the AD brain.

    Full summary, score breakdown and related studies → Original source

  11. 2017-11-22

    Lixisenatide reduces amyloid plaques, neurofibrillary tangles and neuroinflammation in an APP/PS1/tau mouse model of Alzheimer's disease

    ✓ Peer-reviewed Drug development Biochemical and biophysical research communications

    Key finding: We have previously shown that the long-lasting GLP-1 receptor (GLP-1R) agonist lixisenatide plays an important role in memory formation, synaptic plasticity and cell proliferation of rats. +2 more findings

    Full summary, score breakdown and related studies → Original source

  12. 2017-11-22

    Altered neuro-inflammatory gene expression in hippocampus in major depressive disorder

    ✓ Peer-reviewed Hippocampus size on brain scans Progress in neuro-psychopharmacology & biological psychiatry

    Key finding: Analysis revealed 30 genes differentially expressed in MDD compared to controls (FDR<0.05). +3 more findings

    Full summary, score breakdown and related studies → Original source

  13. 2017-11-21

    Computerized cognitive stimulation and engagement programs in older adults with mild cognitive impairment: comparing feasibility, acceptability, and cognitive and psychosocial effects

    ✓ Peer-reviewed Digital health tools Clinical interventions in aging

    Key finding: Both interventions were highly feasible and acceptable and allowed improvement in different aspects of cognitive and psychosocial functioning in MCI subjects. +3 more findings

    Full summary, score breakdown and related studies → Original source

  14. 2017-11-21

    Body mass index and risk of dementia: Analysis of individual-level data from 1.3 million individuals

    ✓ Peer-reviewed Getting a diagnosis Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: The association between BMI and dementia is likely to be attributable to two different processes: a harmful effect of higher BMI, which is observable in long follow-up, and a reverse-causation effect that makes a higher BMI to appear protective when the follow-up is short.

    Full summary, score breakdown and related studies → Original source

  15. 2017-11-20

    Decreased Complexity in Alzheimer's Disease: Resting-State fMRI Evidence of Brain Entropy Mapping

    ✓ Peer-reviewed Cognitive tests and assessment Frontiers in aging neuroscience

    Key finding: Resting-state functional magnetic resonance imaging (rs-fMRI) has been introduced as an alternative approach to assessing brain functional abnormalities in AD patients. +3 more findings

    Full summary, score breakdown and related studies → Original source

  16. 2017-11-17

    Liraglutide restores chronic ER stress, autophagy impairments and apoptotic signalling in SH-SY5Y cells

    ✓ Peer-reviewed Drug development Scientific Reports

    Key finding: Growing evidence suggests that agonists of glucagon-like peptide (GLP-1) receptor exert neuroprotective and neurorestorative effects across a range of experimental models of neuronal degeneration, and, recently, a pilot clinical trial of Liraglutide in Alzheimer’s disease patients showed improvements in cerebral glucose consumption that signifies disease progression.

    Full summary, score breakdown and related studies → Original source

  17. 2017-11-17

    Neurotrophic and Neuroregenerative Effects of GH/IGF1

    ✓ Peer-reviewed Costs and economics International journal of molecular sciences

    Key finding: Although strong findings have shown the positive effects of GH/IGF-1 administration on neuroregeneration in animal models, a very limited number of clinical studies have been conducted in humans. +4 more findings

    Full summary, score breakdown and related studies → Original source

  18. 2017-11-17

    Adherence to Mediterranean diet and subjective cognitive function in men

    ✓ Peer-reviewed Prevention trials European journal of epidemiology

    Key finding: In a multivariate model, compared with men having a MD score in the lowest quintile, those in the highest quintile had a 36% lower odds of a poor SCF score (odds ratio 0.64, 95% CI 0.55-0.75; P, trend < 0.001) and a 24% lower odds of a moderate SCF score (OR 0.76, 95% CI 0.70-0.83; P, trend < 0.001). +1 more finding

    Full summary, score breakdown and related studies → Original source

  19. 2017-11-17

    Bile acid quantification of 20 plasma metabolites identifies lithocholic acid as a putative biomarker in Alzheimer's disease

    ✓ Peer-reviewed Mild cognitive impairment Metabolomics : Official journal of the Metabolomic Society

    Key finding: Levels of lithocholic acid were significantly enhanced in plasma of AD patients (50 ± 6 nM, p = 0.004) compared to healthy controls (32 ± 3 nM). +2 more findings

    Full summary, score breakdown and related studies → Original source

  20. 2017-11-16

    Quantitative EEG power and synchronization correlate with Alzheimer's disease CSF biomarkers

    ✓ Peer-reviewed Tau biomarkers Neurobiology of aging

    Key finding: Decreased CSF amyloid β42 significantly correlated with increased theta and delta GFP, whereas increased p- and t-tau with decreased alpha and beta GFP. +3 more findings

    Full summary, score breakdown and related studies → Original source

  21. 2017-11-16

    An overview of systematic reviews of pharmacological and non-pharmacological interventions for the treatment of behavioral and psychological symptoms of dementia

    ✓ Peer-reviewed Treatments International psychogeriatrics

    Key finding: ABSTRACTBackground:This systematic overview reports findings from systematic reviews of randomized controlled trials of pharmacological and non-pharmacological interventions for behavioural and psychological symptoms of dementia (BPSD). +2 more findings

    Full summary, score breakdown and related studies → Original source

  22. 2017-11-16

    Hospice Care for Patients With Dementia in the United States: A Longitudinal Cohort Study

    ✓ Peer-reviewed End-of-life care Journal of the American Medical Directors Association

    Key finding: Patients with dementia are significantly more likely to be disenrolled from hospice following a long enrollment period compared with patients without dementia. +4 more findings

    Full summary, score breakdown and related studies → Original source

  23. 2017-11-15

    DHA supplementation improves cognitive function via enhancing Aβ-mediated autophagy in Chinese elderly with mild cognitive impairment: a randomised placebo-controlled trial

    ✓ Peer-reviewed Biomarkers Journal of neurology, neurosurgery, and psychiatry

    Key finding: Daily oral DHA supplementation (2 g/day) for 24 months may improve cognitive function and change blood biomarker-related Aβ-mediated autophagy in people with MCI. +1 more finding

    Full summary, score breakdown and related studies → Original source

  24. 2017-11-15

    Cerebral vasoreactivity and intima-media thickness in Down syndrome: A case-control study

    ✓ Peer-reviewed Down syndrome and Alzheimer's Journal of the neurological sciences

    Key finding: In Alzheimer Disease, impaired vasoreactivity has been reported as the results of vascular amyloid deposition. +3 more findings

    Full summary, score breakdown and related studies → Original source

  25. 2017-11-14

    Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimer's disease-type beta-amyloid neuropathological mechanisms

    ✓ Peer-reviewed Disease mechanisms Expert review of neurotherapeutics

    Key finding: Our studies support the hypothesis that intestinal microbiota may help protect against AD, in part, by supporting the generation of select SCFAs, which interfere with the formation of toxic soluble Aβ aggregates.

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →